Collaborating reseachers from the Department of Ophthalmology at the Bonn University Hospital and the Neural Stem Cell Institute in New York have successfully replaced damaged cells in eyes impaired by Age-Related Macular Degeneration (AMD) with human stem cells. This implantation technique, conducted in an animal study is the first of its kind and represents a significant advance in developing personalized treatments for patients suffering from a variety of age-related visual impairment issues.
AMD is the leading cause of permanent visual impairment, affecting 1.8 million Americans aged 40 years and older. Currently there is no cure to AMD, but this research proves that adult stem cells have the ability to replace the cells damaged by the disease, possibly restoring eyesight to the patient.
As stem cell based regenerative treatments emerge, the best source of stem cell will be your own. MSCs can be recovered from your teeth – where they reside within the dental pulp of baby teeth, wisdom teeth and permanent teeth. To learn more about emerging regenerative therapies and to learn how to bank your own valuable stem cells, visit StemSave or call 877-783-6728 (877-StemSave) today.
To view the full article, click here.
The future of Regenerative Medicine is now™.